Fulvestrant, Palbociclib and Erdafitinib in ER+/HER2-/FGFR-amplified Metastatic Breast Cancer
Clinical trial NCT03238196 · COMPLETED
Trial details
- NCT number
- NCT03238196
- Sponsor
- Vanderbilt-Ingram Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-18
- Primary completion
- 2021-04-30
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.